SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 189.55+3.5%Dec 12 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (25373)9/13/1998 7:35:00 PM
From: Mike McFarland  Read Replies (2) of 32384
 
Henry and Thread: Could somebody take the time
to explain the promise of Targretin? I believe
there are trials for breast cancer, cutaneous
t-cell lymphoma, diabetes, psoriasis--
is there anything else that I missed? A summary
of the delivery method too--I've lost track.

Finally can anybody tell me if they have any
anti CD-40 Ligands? I know I am floundering around
here on SI, rarely asking the right questions, but
if anybody can enlighten me I'd sure appreciated it.
Only a few months on the learning curve, and have not
ready an awful lot of the thread yet (embarrassed to
admit it, but have to start somewhere!)

--MM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News